Morgan Stanley has recently reduced Hims & Hers Health Inc (HIMS) stock rating, as announced on February 18, 2025, according to Finviz. Earlier, on January
Goldman has recently reduced Ford Motor Co (F) stock to Neutral rating, as announced on April 10, 2025, according to Finviz. Earlier, on April 9,
Citigroup has recently raised MKS Instruments Inc (MKSI) stock to Buy rating, as announced on January 6, 2025, according to Finviz. Earlier, on December 13,
Mizuho has recently reduced 8×8 Inc (EGHT) stock to Underperform rating, as announced on December 13, 2024, according to Finviz. Earlier, on June 14, 2024,
Piper Sandler has recently raised Qorvo Inc (QRVO) stock to Overweight rating, as announced on January 27, 2025, according to Finviz. Earlier, on January 21,
Oppenheimer has recently raised Biomarin Pharmaceutical Inc (BMRN) stock to Outperform rating, as announced on February 24, 2025, according to Finviz. Earlier, on November 15,
BofA Securities has recently reduced Adient PLC (ADNT) stock to Underperform rating, as announced on March 4, 2025, according to Finviz. Earlier, on December 16,
Raymond James has recently raised Altice USA Inc (ATUS) stock to Outperform rating, as announced on February 18, 2025, according to Finviz. Earlier, on August
BMO Capital Markets has recently initiated Dyne Therapeutics Inc (DYN) stock to Outperform rating, as announced on March 12, 2025, according to Finviz. Earlier, on
DA Davidson has recently initiated Custom Truck One Source Inc (CTOS) stock to Buy rating, as announced on February 16, 2023, according to Finviz. Earlier,
BOVNews.com was originated in 2018 as a Company. Our team comprises Analysts and writers with the knowledge and expertise of Stock Markets and other sectors of Finance.
Copyright©2024, BOVNews.com
